MINNEAPOLIS (AP) — Minnesota inmates with chronic hepatitis C infections have gained access to pricey antiviral drugs following a class-action lawsuit settlement.

The Star Tribune reports that five inmates sued the Minnesota Department of Corrections in 2015, accusing the agency of withholding medication that has a 95 percent cure rate. The drugs range in price from $26,400 to more than $100,000 per patient.

The state agency has argued that providing the drug would overwhelm the state’s corrections budget.

Under the settlement terms that won preliminary approval Monday, the department is required to screen all inmates for hepatitis C. The department must provide the antiviral drugs to an inmate with an advanced stage of the disease, or those who have both hepatitis C and other health complications.

The litigation follows similar calls for the treatment in Pennsylvania and Oklahoma

(© Copyright 2019 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.).


Leave a Reply

Please log in using one of these methods to post your comment:

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.